Perspective Therapeutics, Inc.
AMEX:CATXMedical - Devices
+$0.02 today
- Market cap
- $94.20M
- Beta
- 1.73
- P/E (TTM)
- -0.0
- EPS (TTM)
- -$107.27
Volume 2.69M
Average 1.44M
CATX Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Perspective Therapeutics, Inc.AMEX: CATX
Net Debt · Q1 FY2026 · quarter ended Mar 2026
Net debt remains negative
Q1 FY2026 net debt was -$51.35M, compared with -$40.59M a year earlier.
Context
- Net debt amounted to 12.5% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Net debt grew in size in 1 of the last 3 fiscal years.
What to watch
Whether net debt keeps falling in the next quarterly balance sheet after a -26.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- (29M) USD
- Year-over-year change
- +49.6%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (29M) | +49.6% |
| FY2024 | 2024-12-31 | (57.52M) | -760.1% |
| FY2023 | 2023-12-31 | (6.69M) | +68.1% |
| FY2022 | 2022-12-31 | (20.99M) | +64.8% |
| FY2021 | 2022-06-30 | (59.7M) | — |
Net Debt vs competitors
How CATX compares with its peers on the latest reported figures
- CATX's Mar 2026 net debt of -$51.35M is the lowest of the 5 companies compared; the peer median is -$19.99M.
- Its year-over-year change of -26.5% is the 2nd highest of 5, against a peer median of -142.8%.
- Net debt amounts to 12.5% of total assets for CATX, versus a peer median of 31.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $137.62M | -75.8% | -26.4% | 17.5% | |
| Mar 2026 | -$17.92M | +2.7% | — | 34.8% | |
| Mar 2026 | -$22.07M | -209.7% | — | 31.1% | |
| Mar 2026 | -$40.41M | -243.6% | — | 32.4% | |
| Mar 2026 | -$51.35M | -26.5% | — | 12.5% | |
| Peer median (excluding CATX) | -$19.99M | -142.8% | -26.4% | 31.7% | |
Competitors are the stored peer set for CATX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jun 2022 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 60.35M | 20.99M | 9.24M | 61.58M | 30.63M |
| Short-term Investments | 0 | 22.76M | 0 | 165.34M | 114.11M |
| Net Receivables | 1.65M | 1.36M | 1.18M | 116K | 6K |
| Inventory | 1.07M | 1.41M | 0 | 0 | 0 |
| Other Current Assets | 535K | 6.69M | 5.35M | 4.13M | 3.65M |
| Total Current Assets | 63.6M | 53.22M | 16.84M | 231.16M | 148.39M |
| Property, Plant & Equipment (Net) | 2.62M | 2.06M | 6.32M | 59.54M | 78.1M |
| Goodwill | 0 | 0 | 24.06M | 0 | 0 |
| Intangible Assets | 107K | 86K | 50.35M | 50M | 40M |
| Long-term Investments | 0 | 150K | 133K | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 926K | (2.3M) | 182K | 405K | 486K |
| Total Non-current Assets | 3.65M | 2.3M | 81.05M | 109.94M | 118.58M |
| Total Assets | 67.25M | 58.09M | 97.89M | 341.1M | 266.97M |
| Account Payables | 847K | 1.54M | 6.91M | 10.34M | 20.51M |
| Short-term Debt | 0 | 0 | 49K | 52K | 623K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 1.4M | 26.6M |
| Other Current Liabilities | 259K | (406K) | 4.73M | 5.48M | 1.46M |
| Total Current Liabilities | 1.85M | 2.68M | 15.66M | 18.23M | 28.68M |
| Long-term Debt | 0 | 0 | 1.68M | 1.63M | 1.01M |
| Deferred Tax Liabilities | 0 | 0 | 4.59M | 2.5M | 1.7M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 26.6M | 0 |
| Other Non-current Liabilities | 624K | 75K | 4.59M | 55K | 28.56M |
| Total Non-current Liabilities | 1.02M | 331K | 7.05M | 32.2M | 31.26M |
| Total Liabilities | 2.86M | 3.45M | 22.71M | 50.43M | 59.94M |
| Common Stock | 142K | 142K | 282K | 70K | 74K |
| Retained Earnings | (95.17M) | (105.93M) | (152.44M) | (231.72M) | (334.84M) |
| Accumulated OCI | 0 | 0 | 0 | (51K) | 110K |
| Other Stockholders Equity | 0 | 160.43M | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 64.39M | 54.64M | 75.18M | 290.67M | 207.03M |
| Total Debt | 652K | 524K | 2.55M | 4.06M | 1.63M |
| Net Debt | (59.7M) | (20.99M) | (6.69M) | (57.52M) | (29M) |
Perspective Therapeutics, Inc.
AMEX:CATX
Intrinsic Alpha fair value
Locked
Current Price
$0.78
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.